The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Blood Stream Infection Testing Market Research Report 2024
Synopsis
BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
The global Blood Stream Infection Testing market was valued at US$ 3679.1 million in 2023 and is anticipated to reach US$ 5862.7 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Stream Infection Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Stream Infection Testing.
Report Scope
The Blood Stream Infection Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Stream Infection Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Stream Infection Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX
Segment by Type
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing
Segment by Application
Hospitals
Independent Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Stream Infection Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
The global Blood Stream Infection Testing market was valued at US$ 3679.1 million in 2023 and is anticipated to reach US$ 5862.7 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Stream Infection Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Stream Infection Testing.
Report Scope
The Blood Stream Infection Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Stream Infection Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Stream Infection Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX
Segment by Type
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing
Segment by Application
Hospitals
Independent Diagnostic Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Stream Infection Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Stream Infection Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Conventional Blood Culture Tests
1.2.3 PCR Methods
1.2.4 Nucleic Acid Testing
1.2.5 Mass Spectroscopy
1.2.6 Point of Care Testing
1.3 Market by Application
1.3.1 Global Blood Stream Infection Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Independent Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Stream Infection Testing Market Perspective (2019-2030)
2.2 Blood Stream Infection Testing Growth Trends by Region
2.2.1 Global Blood Stream Infection Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Stream Infection Testing Historic Market Size by Region (2019-2024)
2.2.3 Blood Stream Infection Testing Forecasted Market Size by Region (2025-2030)
2.3 Blood Stream Infection Testing Market Dynamics
2.3.1 Blood Stream Infection Testing Industry Trends
2.3.2 Blood Stream Infection Testing Market Drivers
2.3.3 Blood Stream Infection Testing Market Challenges
2.3.4 Blood Stream Infection Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Stream Infection Testing Players by Revenue
3.1.1 Global Top Blood Stream Infection Testing Players by Revenue (2019-2024)
3.1.2 Global Blood Stream Infection Testing Revenue Market Share by Players (2019-2024)
3.2 Global Blood Stream Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Stream Infection Testing Revenue
3.4 Global Blood Stream Infection Testing Market Concentration Ratio
3.4.1 Global Blood Stream Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Stream Infection Testing Revenue in 2023
3.5 Blood Stream Infection Testing Key Players Head office and Area Served
3.6 Key Players Blood Stream Infection Testing Product Solution and Service
3.7 Date of Enter into Blood Stream Infection Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Stream Infection Testing Breakdown Data by Type
4.1 Global Blood Stream Infection Testing Historic Market Size by Type (2019-2024)
4.2 Global Blood Stream Infection Testing Forecasted Market Size by Type (2025-2030)
5 Blood Stream Infection Testing Breakdown Data by Application
5.1 Global Blood Stream Infection Testing Historic Market Size by Application (2019-2024)
5.2 Global Blood Stream Infection Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Stream Infection Testing Market Size (2019-2030)
6.2 North America Blood Stream Infection Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Stream Infection Testing Market Size by Country (2019-2024)
6.4 North America Blood Stream Infection Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Stream Infection Testing Market Size (2019-2030)
7.2 Europe Blood Stream Infection Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Stream Infection Testing Market Size by Country (2019-2024)
7.4 Europe Blood Stream Infection Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Stream Infection Testing Market Size (2019-2030)
8.2 Asia-Pacific Blood Stream Infection Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Stream Infection Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Stream Infection Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Stream Infection Testing Market Size (2019-2030)
9.2 Latin America Blood Stream Infection Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Stream Infection Testing Market Size by Country (2019-2024)
9.4 Latin America Blood Stream Infection Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Stream Infection Testing Market Size (2019-2030)
10.2 Middle East & Africa Blood Stream Infection Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Stream Infection Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Stream Infection Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Blood Stream Infection Testing Introduction
11.1.4 BD Revenue in Blood Stream Infection Testing Business (2019-2024)
11.1.5 BD Recent Development
11.2 bioMérieux
11.2.1 bioMérieux Company Detail
11.2.2 bioMérieux Business Overview
11.2.3 bioMérieux Blood Stream Infection Testing Introduction
11.2.4 bioMérieux Revenue in Blood Stream Infection Testing Business (2019-2024)
11.2.5 bioMérieux Recent Development
11.3 Cepheid
11.3.1 Cepheid Company Detail
11.3.2 Cepheid Business Overview
11.3.3 Cepheid Blood Stream Infection Testing Introduction
11.3.4 Cepheid Revenue in Blood Stream Infection Testing Business (2019-2024)
11.3.5 Cepheid Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Blood Stream Infection Testing Introduction
11.4.4 Roche Diagnostics Revenue in Blood Stream Infection Testing Business (2019-2024)
11.4.5 Roche Diagnostics Recent Development
11.5 IRIDICA
11.5.1 IRIDICA Company Detail
11.5.2 IRIDICA Business Overview
11.5.3 IRIDICA Blood Stream Infection Testing Introduction
11.5.4 IRIDICA Revenue in Blood Stream Infection Testing Business (2019-2024)
11.5.5 IRIDICA Recent Development
11.6 Bruker
11.6.1 Bruker Company Detail
11.6.2 Bruker Business Overview
11.6.3 Bruker Blood Stream Infection Testing Introduction
11.6.4 Bruker Revenue in Blood Stream Infection Testing Business (2019-2024)
11.6.5 Bruker Recent Development
11.7 Nanosphere
11.7.1 Nanosphere Company Detail
11.7.2 Nanosphere Business Overview
11.7.3 Nanosphere Blood Stream Infection Testing Introduction
11.7.4 Nanosphere Revenue in Blood Stream Infection Testing Business (2019-2024)
11.7.5 Nanosphere Recent Development
11.8 Siemens
11.8.1 Siemens Company Detail
11.8.2 Siemens Business Overview
11.8.3 Siemens Blood Stream Infection Testing Introduction
11.8.4 Siemens Revenue in Blood Stream Infection Testing Business (2019-2024)
11.8.5 Siemens Recent Development
11.9 AdvanDX
11.9.1 AdvanDX Company Detail
11.9.2 AdvanDX Business Overview
11.9.3 AdvanDX Blood Stream Infection Testing Introduction
11.9.4 AdvanDX Revenue in Blood Stream Infection Testing Business (2019-2024)
11.9.5 AdvanDX Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
